Phase 2 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 19 years old or older
- You have been diagnosed with androgenetic alopecia (a common type of hair loss sometimes called male or female pattern baldness)
- You are willing to keep the same hairstyle, hair length, and hair color throughout the study
- You are willing to avoid certain hair products or treatments that are not allowed during the study
- You are willing to have a small area of your scalp temporarily tattooed and your hair trimmed in that area so photos can be taken to measure hair growth
- You are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have used certain medications or treatments that affect hair growth within a time period set by the study rules (confirm with trial site)
- You have a scalp condition or hair disorder other than androgenetic alopecia
- You have an autoimmune disease that affects your scalp or hair (such as alopecia areata — confirm with trial site)
- You have a significant ongoing health condition affecting your heart, kidneys, hormones, or immune system, or a serious infection
- You have tested positive for hepatitis B, hepatitis C, HIV, or syphilis
- You have previously had a hair transplant, stem cell therapy, or gene therapy
- You have a known allergy or sensitivity to the study treatment or any of the study procedures
- You are currently pregnant or breastfeeding
- You have taken part in another clinical trial within a time period set by the study rules (confirm with trial site)
- The study doctor has determined for any other reason that the study may not be appropriate for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82-70-4209-0556
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Dose-Limiting Toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.